Matt LimbGene expressionMIT team develops genome-editing approach for cancer mutation screeningScientists say they have developed a method to screen cancer-associated genetic mutations more easily and quickly than any existing approach.March 22, 2024SequencingCurio Bioscience to offer single-cell spatial mapping kitCurio Bioscience is offering researchers early access to a product which it claims is the first in the world to transform single-cell genomics data into spatial context.March 19, 2024Research ConsortiumInternational consortium launches project to develop next generation of vaccinesAn international consortium of researchers specializing in human challenge studies is embarking on a $57 million project to develop advanced virus-blocking coronavirus vaccines.March 15, 2024Antibiotic ResistanceHarvard team develops compound to combat drug-resistant bacteriaHarvard University researchers say they have created an antibiotic that can overcome many drug-resistant infections.March 13, 2024Laboratory Information Systems (LIS)Metabolon releases integrated bioinformatics platformMetabolon has launched an integrated bioinformatics platform to aid metabolomics analysis in life sciences research.March 12, 2024Prostate CancerStudy: AI assists discovery of prostate cancer subtypesProstate tumors have been found to evolve along multiple pathways, leading to two distinct disease types with “pivotal” implications for diagnosis and treatment, say scientists.March 8, 2024Technology TransferMD Anderson Cancer Center acquires cell therapy switch technologiesThe University of Texas MD Anderson Cancer Center has acquired inducible switch technologies for development in cell therapy programs from Bellicum Pharmaceuticals.March 7, 2024CollaborationGinkgo Bioworks launches technology networkGinkgo Bioworks has launched a new technology network with 25 partners, pledging to improve customers’ research and development outcomes.March 6, 2024CollaborationMD Anderson Cancer Center, C-Biomex collaborate on CA9-targeting radioligandThe University of Texas MD Anderson Cancer Center has signed an agreement with South Korean company C-Biomex to co-develop CBT-001, a radioligand targeting the CA9 cancer biomarker.February 29, 2024Group A StreptococcusGlobal research network launches to fight strep A infectionsScientists have launched a global research network to combat deadly strep A infections that can trigger sepsis and heart damage in children.February 27, 2024Previous PagePage 2 of 9Next PageTop StoriesPCRQiagen partners with FBI on forensics assayQiagen has announced a collaboration with the FBI to develop a new assay to improve DNA quantification for use in forensics and human identification.ImmunoassaysUniversity of Florida researchers develop CRISPR-based assay for HPV detectionFDA ClearanceGeneoscopy receives FDA approval for CRC screening testLawsuitGerman court rules patent invalid in 10x infringement suit against NanoStringSponsor ContentVisit our Molecular Diagnostics Community
